As US lawmakers inch closer to lifting the onerous restrictions on research into medicinal cannabis, the need for interdisciplinary collaboration between the pharmaceutical and cannabis industries has never been clearer, or more essential. Canna Pharma 2022 will feature a two-track program devoted to non-pharmaceutical (or nutraceutical) cannabis product development, safety testing, quality control, and regulatory compliance (Day One) AND expanded, in-depth coverage of cannabinoid-derived pharmaceutical development and the regulatory expectations for novel cannabis-based pharmaceutical products (Day Two). Canna Pharma 2022, in partnership with EAS Consulting, will also provide an expert how-to workshop on GMPs for the cannabis industry, helping you and your employees meet critical quality and regulatory expectations.

Regulators in North America and Europe are requiring stricter standards for environmental monitoring systems, facility cleaning and disinfectant qualification, aseptic cleanroom operations, filtration, sterilization, and aseptic process simulation (or media fill). This two-day summit features expert insight into the robust aseptic processing requirements facing the industry. Pharma Ed’s Aseptic Processing Summit features comprehensive coverage on the implementation and management of the latest knowledge in aseptic, barrier, containment, and aseptic best practice technologies.